Terence Kin-Wah Lee

29PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 02, 2026
p38β-mediated BiP phosphorylation drives stemness and chemoresistance by suppressing UPR activation in hepatocellular carcinoma.

|Jun 19, 2026
Chemical-Assembled Macrophage-Engaging Glypican-3 × Signal Regulatory Protein-α (SIRP-α) Bispecific Antibody for Immunotherapy Against Liver Cancer.

|Dec 25, 2025
Targeting cancer stem cells enhances multikinase inhibitor therapy in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma.

Yasi Pan, Xiang Zhang, Chi Chun Wong

|Nov 11, 2025
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma.

Martina Mang Leng Lei, Carmen Oi Ning Leung, Rainbow Wing Hei Leung

|Jul 30, 2025
AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse models.

Kai-Yu Ng, Tin-Yan Koo, Ianto Bosheng Huang

|Jul 29, 2025
Polypharmacology-Driven Discovery of ZAK-I-57: A Potent Multi-Targeted Benzoxazinone Small Molecule for Hepatocellular Carcinoma Therapy.

Shakeel Ahmad Khan, Huihai Yang, Fan Ying

Pageof 5

Frequent Collaborators

15 joint publications

Stephanie Ma

7 joint publications

Tin-Lok Wong

6 joint publications

Man Tong

5 joint publications

Irene Oi-Lin Ng